TNAX Biopharma Company

TNAX Biopharma is a developer of pharmaceuticals drugs intended to improve the quality of life of patients.
Technology:
Anti-infective Drugs
Headquarters:
Asia-Pacific (APAC)
Funding Status:
Early Stage Venture
Founded Date:
2018
Estimated Revenue:
$1M to $10M
Employee Number:
1-10
Industry:
PharmTech